Recent Headlines
Within Research & Development in the Physical, Engineering, & Life Sciences
LSU’s Pennington Biomedical Brings Science-Backed Childhood Obesity Prevention Into 32 Louisiana Schools, Preschools
Greaux Healthy is a comprehensive, new program supported by the State of Louisiana that translates 35 years of Pennington Biomedical research into practical tools to prevent and treat childhood obesity - March 27, 2025 - Pennington Biomedical Research Center
Accofrisk Platform Will Measure More Than 100 Health Parameters Remotely
Accofrisk has announced the global launch of its remote non-invasive health monitoring platform. - March 22, 2025 - Accofrisk
Visionary Entrepreneur and Telemedicine Pioneer Michael Gorton Surprises Readers with Thrilling Sci-Fi Sequel "Tachyon Tunnel 2," Launching March 10
Visionary entrepreneur and telemedicine pioneer Michael Gorton surprises readers with "Tachyon Tunnel 2," the thrilling sequel to his award-winning sci-fi novel. Launching March 10, the book follows Alex and the Tranquility team as they face the unstoppable Daklin Empire, rulers of the galaxy for 50 million years. Blending real physics with gripping adventure, Tachyon Tunnel 2 cements Gorton’s place as a master storyteller. Available in print, digital, and audiobook formats. - March 11, 2025 - Michael Gorton
eg technology Bolsters Global Presence with Appointment of Paul Anglim
eg technology Ltd. make key appointment as Paul Anglim joins the specialist product design, engineering and development consultancy as they continue their international expansion. - March 11, 2025 - eg technology Ltd
Accofrisk Has Started Developing Non-Invasive Pocket Devices for Health Monitoring
Accofrisk announced the start of development of pocket-sized wearable devices for non-invasive health monitoring. - March 07, 2025 - Accofrisk
HistAI Unveils Groundbreaking SPIDER Initiative at HIMSS Conference
At the HIMSS Conference, HistAI announced the SPIDER Initiative, an open-source project set to become the largest supervised medical imaging dataset. The initiative will compile more than 50 millions of fully annotated images from 20 organs and 400 morphologies, advancing AI-driven diagnostics, precision medicine, and drug development. The first release includes more than 4 millions of images from 6K Whole Slide Images (WSIs) across Skin, Colorectal, and Thorax. Available starting today. - March 06, 2025 - HistAI
AI MINDSystems Foundation and GenoBank.io Announce Strategic Partnership at ETHDenver to Advance Decentralized Biobanking and Healthcare Innovation
AI MINDSystems and GenoBank.io partner at ETHDenver to advance decentralized biobanking. Integrating GenoBank.io’s BioNFT™ into the AI MINDSystems Trusted Data Ecosystem™ empowers individuals with control over their biosamples via ‘lockable’ NFTs. This collaboration aims to create secure, privacy-preserving solutions for digital biology, precision health, and research, using blockchain and Web3 technologies. They also plan to launch WISDOM Networks™ for data-driven healthcare transformation. - February 28, 2025 - AI MINDSystems Foundation
Pennington Biomedical Researchers Uncover Role of Hormone in Influencing Brain Reward Pathway and Food Preferences
Dr. Christopher Morrison led team in discovering regulating role of hormone FGF21 for brain reward pathways, research published in Molecular Metabolism - February 28, 2025 - Pennington Biomedical Research Center
Pennington Biomedical Researchers Assemble Comprehensive History of Electronic Health Records
Published in the Journal of Medical Internet Research, Dr. Yun Shen and Dr. Gang Hu explore 25 years of electronic health records’ secondary purpose - the interoperability with research - February 21, 2025 - Pennington Biomedical Research Center
New Greaux Healthy Toolkit Empowers Healthcare Providers with Evidence-Based Strategies for Childhood Obesity Prevention and Treatment
Greaux Healthy—a public service initiative powered by Pennington Biomedical Research Center, in partnership with the State of Louisiana—is proud to announce the release of the Childhood Obesity Prevention, Evaluation and Treatment Toolkit, a comprehensive resource designed to equip... - February 21, 2025 - Pennington Biomedical Research Center
Pennington Biomedical Contributes to Study Advancing Medical Imaging on Body Fat and Muscle Distribution
Dr. Steven Heymsfield part of research group advancing 3D imaging and deep learning techniques. - February 06, 2025 - Pennington Biomedical Research Center
Access EETech’s 2024 Engineering Insights Report: An Electronics Industry Reveal of the Latest Trends and Insights
Engineering Insights Report (EIR), featuring over 4,500 highly qualified engineer responses worldwide. - January 22, 2025 - EETech Media
Pennington Biomedical Researchers Serve on Global Commission on Clinical Obesity
Commission goes that goes beyond BMI in defining obesity as a disease. - January 18, 2025 - Pennington Biomedical Research Center
Global Launch for Clinical Obesity Definition to be Held Jan. 16, Pennington Biomedical Serving as North American Satellite Hub
Three researchers from Pennington Biomedical served on the 56-member Lancet Commission on Clinical Obesity - January 16, 2025 - Pennington Biomedical Research Center
DASH Diet Recognized as Best Heart-Healthy Diet, Ranks as Second-Best Diet Overall
The Dietary Approaches to Stop Hypertension, or DASH, Diet, developed in part by Pennington Biomedical Research Center scientists, has been recognized as the second-best diet overall and the best heart-healthy diet in the 2025 U.S. News & World Report Best Diets Rankings. - January 08, 2025 - Pennington Biomedical Research Center
Small Shifts for the New Year from Researchers at Pennington Biomedical
New Year’s Day provides a fresh start and is a time when people set goals and resolutions for the year ahead. Many of those will focus on healthy eating, exercise or mental health, but drastic lifestyle changes are hard to adopt and typically are challenging to sustain. Instead, researchers... - December 26, 2024 - Pennington Biomedical Research Center
Pennington Biomedical Celebrates Employees for Service Milestones
Fourteen employees recognized for 20 years or more of service at Pennington Biomedical. - December 23, 2024 - Pennington Biomedical Research Center
Pennington Biomedical Conducts Study to Test Efficacy of Diabetes Medication for Cancer-Related Weight Loss
Dr. Justin Brown of Pennington Biomedical invites patients with lung or gastrointestinal cancers to participate in National Cancer Institute-funded trial. - December 23, 2024 - Pennington Biomedical Research Center
Impact of Government Assistance, Housing, and Employment on Postpartum Maternal Health Across Income and Race
Stressful periods such as COVID-19, hurricanes or infant formula shortages negatively impact racial groups differently. - December 13, 2024 - Pennington Biomedical Research Center
The Role of Digital Technology in Diabetes Prevention and Management
Scientists at Pennington Biomedical Research Center, along with a colleague from Peking University People’s Hospital in China, have been leading a special collection and published an editorial in Frontiers in Endocrinology, emphasizing the transformative role digital health technologies play... - December 07, 2024 - Pennington Biomedical Research Center
Metabolic and Bariatric Surgery Safe and Effective for Patients with Severe Obesity
A multicenter examination of data demonstrates that for patients with a body mass index at or above 70 kg/m2 metabolic and bariatric surgery is a potent intervention. - December 07, 2024 - Pennington Biomedical Research Center
Dr. Stephanie Waldrop Joins Pennington Biomedical Research Center
New at Pennington Biomedical: Get to Know Dr. Stephanie Waldrop, assistant professor in Clinical Sciences - December 06, 2024 - Pennington Biomedical Research Center
Pennington Biomedical Researchers Share Tips for the Holiday Season
From breakfast to holiday desserts, there are numerous ways to introduce small, manageable changes to your celebration. - November 20, 2024 - Pennington Biomedical Research Center
Let’s Win Pancreatic Cancer Selects TrialX to Launch Its First AI-Powered Global Clinical Trial Finder
Let’s Win Pancreatic Cancer, a go-to resource that guides patients and caregivers with vital information for better outcomes, launches a new global AI-based clinical trial finder - powered by TrialX - that aims to increase accessibility of clinical trial information for patients and families affected by pancreatic cancer. - November 19, 2024 - TrialX
Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17
The FOXG1 Research Foundation, the parent-led organization that is radically transforming the rare disease drug development landscape, is hosting an international conference in Fort Lauderdale from November 15-17, bringing families from across the globe together to learn about gene therapy advancements for FOXG1 syndrome. A highlight includes a presentation by 20-year-old Abraham Weitzman, who, though non-speaking, shares his lived experience using an innovative communication device. - November 04, 2024 - FOXG1 Research Foundation
GlycoMira Therapeutics Receives Key Patent for First-in-Class Oncology Therapeutic
Key patent covering GlycoMira's lead compound GM-1111 adds to the Company's already strong IP portfolio. - November 04, 2024 - GlycoMira Therapeutics, Inc.
Pennington Biomedical to be on Display at ObesityWeek 2024 in San Antonio
ObesityWeek is home to the latest developments in evidence-based obesity science. - November 02, 2024 - Pennington Biomedical Research Center
Minor Use Foundation Awarded $2M Grant from Assisting Specialty Crop Exports Initiative
Foundation to Support ASCE Project “Increasing Data Generation for Codex and Harmonized MRL Setting” - October 28, 2024 - Minor Use Foundation, Inc.
Zubaidah Nor Hanipah Joins Pennington Biomedical Research Center and the Metamor Institute
Get to Know Dr. Zubaidah "Zuby" Nor Hanipah, professor-research in clinical metabolic surgery. - October 26, 2024 - Pennington Biomedical Research Center
Pennington Biomedical's EAT2 Study to Explore Unknown Effects of Weight Fluctuations
The EAT2 study is recruiting participants now, and participants will be randomly assigned to the two groups - a control group that is weight stable and group with a diet that promotes weight gain. Both groups will participate in a dietary intervention program for 8 weeks, but those in the weight gain group will also be provided with an eight-week weight loss treatment following the dietary intervention. - October 26, 2024 - Pennington Biomedical Research Center
ClinTrial Research (CTR) Welcomes Wendy Tomlinson as the Company’s Chief Operating Officer
ClinTrial Research (CTR), proudly welcomes Wendy Tomlinson as the company’s Chief Operating Officer. Tomlinson will oversee activities related to clinical operations, project management, project delivery, and portfolio management. “I am excited for this new chapter and to have the... - October 07, 2024 - ClinTrial Research
Pennington Biomedical Partners on Army-Wide Health and Nutrition Study
Pennington Biomedical’s Center for Military Performance and Resilience and the U.S. Army Research Institute of Environmental Medicine collaborate on study; Louisiana’s Fort Johnson is first installation visit for study. - October 06, 2024 - Pennington Biomedical Research Center
Award-Winning Cleantech Startup Joins Cummings Properties' Woburn, MA Innovation Cluster
Active Surfaces, an early-stage solar technology company, expanded from Greentown Labs' cleantech incubator in Somerville, MA to a dedicated R&D facility in Cummings Properties' Woburn, MA innovation cluster. - October 05, 2024 - Cummings Properties
BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BUHLMANN fCAL® turbo and fPELA® turbo Assays
BÜHLMANN Laboratories AG, a leading manufacturer of specialty, high-quality in-vitro diagnostic and research assays, is pleased to announce the collaboration with Beckman Coulter for a worldwide distribution of the BÜHLMANN fCAL® turbo assay & BÜHLMANN fPELA® turbo assay... - September 26, 2024 - BUHLMANN Diagnostics Corp
SEMA Lab Launches Crowdfunding Campaign for Ultrasound-Enhanced Meditation Retreat
The Science Enhanced Mindful Awareness (SEMA) Lab, co-directed by Dr. Jay Sanguinetti and world-renowned mindfulness teacher Shinzen Young, has officially launched a crowdfunding campaign to support their latest research endeavor: the world’s first ultrasound-enhanced meditation retreat. - September 13, 2024 - SEMA Lab
Pennington Biomedical’s Greaux Healthy Initiative Takes Aim at Childhood Obesity
Launch coincides with Childhood Obesity Awareness month; Campaign to share Pennington Biomedical research-sourced educational resources with physicians, educators, and families - September 08, 2024 - Pennington Biomedical Research Center
Pennington Biomedical's September Small Shift Focus is Hydration
This month, the Small Shifts Squad at Pennington Biomedical Research Center will focus on something simple yet incredibly impactful: hydrating more. Staying properly hydrated is essential for maintaining energy levels, improving concentration, and supporting overall health. This month, Small... - September 06, 2024 - Pennington Biomedical Research Center
Pennington Biomedical Research Center Adds Director of Intellectual Property and Commercialization
Reis Alsberry Joins Pennington Biomedical Research Center to lead intellectural property and commercialization efforts. - August 23, 2024 - Pennington Biomedical Research Center
Pennington Biomedical Researcher Dr. Eric Ravussin Joined Experts from Around the World, Agreeing on Fasting Terminology to Boost Global Research
Scientists reach consensus for fasting terminology. - August 11, 2024 - Pennington Biomedical Research Center
Pennington Biomedical Scientists Outline Key Challenges and Promising Avenues in Obesity Genetics
Research article by Pennington Biomedical’s Dr. Sujoy Ghosh and Dr. Claude Bouchard included in the International Journal of Obesity - August 02, 2024 - Pennington Biomedical Research Center
CleverLMS Continues to Improve User Experience by Introducing Offline Mode for Taskhub
CleverLMS is excited to announce the latest enhancement to our platform: the Offline TaskHub feature. This new functionality allows users to continue their workflow seamlessly, even without an internet connection. Report data that employees wish to send is fully saved in a draft if the internet... - July 29, 2024 - CleverLMS
Busch Marine Inc. is Launching a Search Mission for the Wreck of SS I’m Alone
Busch Marine Inc., with locations in Plainwell, Freeland, and Carrollton Michigan, is embarking on a search mission for the wreck of the SS I’m Alone. This deep ocean search will be conducted in the Gulf of Mexico at a depth of 12,000 to 16,000 feet. The SS I’m Alone was a renowned... - July 24, 2024 - Busch Marine Inc.
Pennington Biomedical’s Small Shift for July: Prioritizing Sleep
Small shifts can make a big impact on a person’s long-term health, and that includes catching some Z's. Quality sleep is essential for physical health, mental clarity and emotional resilience. This month, making a few small adjustments to sleep routines can enhance overall health and energy levels. - July 13, 2024 - Pennington Biomedical Research Center
Celebrate National Blueberry Month with Pennington Biomedical
The health benefits of blueberries are believed to be due to the diverse range of phytochemicals they contain, that act as antioxidants, anticancer agents, anti-neurodegenerative agents and anti-inflammatory agents. Because of these properties, many studies have been conducted to evaluate the health benefits of blueberries in chronic disease prevention. - July 10, 2024 - Pennington Biomedical Research Center
Immundiagnostik, Inc. Partners with BioPorto Diagnostics A/S to Expand Renal Research Offering
Immundiagnostik, Inc. has partnered with BioPorto Diagnostics A/S to expand its product portfolio to include BioPorto's line of NGAL ELISAs. - July 01, 2024 - Immundiagnostik, Inc.
Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science
Cambridge Polymer Group (CPG) announced a new leadership structure to better support clients in developing innovative products. CPG is creating a new five-person senior management team with deep materials science expertise, which will allow for closer collaboration with clients on complex projects. Dr. Gavin Braithwaite will be the new CEO and Dr. Stephen Spiegelberg will move to the new role of Chief Scientific Officer (CSO). - June 23, 2024 - Cambridge Polymer Group
Pennington Biomedical Shares Small Shifts for Nutritional Health
As a world-renowned nutrition research center, Pennington Biomedical has been on the forefront of how diet impacts health for decades. With hundreds of studies demonstrating the value of sound nutrition, the research center rolled out its Small Shifts campaign this year to showcase the cumulative value of daily common-sense changes. - June 23, 2024 - Pennington Biomedical Research Center
Simplifying Clinical Trials: TrialX Launches AI powered Clinical Trial Finder for Patient-Friendly Information
TrialX's new AI powered Clinical Trial Finder tool simplifies access to detailed information on over 58,000 active trials globally. The advanced AI technology transforms complex trial details into clear, concise language, making them understandable for a broader audience. Patients and caregivers can register as volunteers and receive notifications about suitable trials, enhancing participation in clinical research. - June 17, 2024 - TrialX
Groundbreaking Study Shows Promise in AAV9 Gene Therapy for FOXG1 Syndrome; Rescue of Brain Structure Abnormalities and Deficits.
New publication shows groundbreaking result in FOXG1 AAV9 gene therapy studies, rescuing structural brain abnormalities caused by the pediatric rare disease, FOXG1 syndrome. This paper summarizing work done by the FOXG1 Research Center, led by Dr. Soo-Kyung Lee, Dr. Jae W. Lee and Dr. Kathrin Meyer (responsible for the SMA gene therapy), shows remarkable rescue of brain abnormalities using AAV9 gene therapy. - June 10, 2024 - FOXG1 Research Foundation
Immundiagnostik, Inc. Launches New and Improved Website
Immundiagnostik, Inc. announces the launch of its new and improved website, making it easier for researchers and clinical lab professionals to find the immunoassays and ELISAs they need. - June 03, 2024 - Immundiagnostik, Inc.